Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

Substantial COVID-19 research investment has been allocated to randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine, which currently face recruitment challenges or early discontinuation. We aim to estimate the effects of hydroxychloroquine and chloroquine on survival in COVID-19 from...

Full description

Bibliographic Details
Main Authors: Axfors, C, Schmitt, AM, Janiaud, P, Van't Hooft, J, Abd-Elsalam, S, Abdo, EF, Abella, BS, Akram, J, Amaravadi, RK, Angus, DC, Arabi, YM, Azhar, S, Baden, LR, Baker, AW, Belkhir, L, Benfield, T, Berrevoets, MAH, Chen, C-P, Chen, T-C, Cheng, S-H, Cheng, C-Y, Chung, W-S, Cohen, YZ, Cowan, LN, Dalgard, O, de Almeida E Val, FF, de Lacerda, MVG, de Melo, GC, Derde, L, Dubee, V, Elfakir, A, Gordon, AC, Hernandez-Cardenas, CM, Hills, T, Hoepelman, AIM, Huang, Y-W, Igau, B, Jin, R, Jurado-Camacho, F, Khan, KS, Kremsner, PG, Kreuels, B, Kuo, C-Y, Le, T, Lin, Y-C, Lin, W-P, Lin, T-H, Lyngbakken, MN, McArthur, C, McVerry, BJ, Nichol, A
Format: Journal article
Language:English
Published: Springer Nature 2021

Similar Items